Author:
Gopinath Chirukandath,Mowat Vasanthi
Reference83 articles.
1. Valentine BA, Hermanson JW. Pathology methods in nonclinical neurotoxicity studies: evaluation of muscle. In: Bolon B, Butt MT, editors. Fundamental neuropathology for pathologists and toxicologists. Hoboken: John Wiley and Sons; 2011. p. 239–52.
2. Alleva FR, Haberman BH, Slaughter LJ, Balazs T. Muscular degeneration in rats after postnatal treatment with 6-mercaptopurine. Drug Chem Toxicol. 1981;4:133–46.
3. Alleva FR, Slaughter LJ, Abraham AA, Balazs T. Further studies on 6-mercaptopurine-induced muscle atrophy in rats, mice, and hamsters treated as neonates. Pediatr Pharmacol (New York). 1984;4:39–48.
4. Alleva FR, Slaughter LJ, Abraham AA, Balazs T. Toxicological studies with 6-mercaptopurine in neonates. Toxicol Ind Health. 1986;2:11–23.
5. Westwood FR, Bigley A, Randall K, Marsden AM, Scott RC. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol. 2005;33:246–57.